THE USE OF MONOCLONAL-ANTIBODIES AND ANTIBODY FRAGMENTS IN THE IMAGING OF INFECTIOUS LESIONS

被引:135
作者
BECKER, W [1 ]
GOLDENBERG, DM [1 ]
WOLF, F [1 ]
机构
[1] CTR MOLEC MED & IMMUNOL, NEWARK, NJ 07103 USA
关键词
D O I
10.1016/S0001-2998(05)80228-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The advantage of immunoscintigraphy over autologous leukocyte techniques in the imaging of infection is the simplicity of its use compared with techniques that require the isolation of autologous white blood cells. The advantage over 99mTc- or 111In-labeled non-specific human immunoglobulin is the excellent targetto-background ratio, which results from an endogenous background subtraction with the whole antigranulocyte antibody (99mTc-anti-NCA-95; BW250/183) and a rapid clearance of the antibody using an antigranulocyte Fab-fragment (99mTc-anti-NCA-90; IMMU-MN3). The whole antibody is helpful for imaging of soft tissue infections, peripheral bone, and abdominal infections. Problems may arise occasionally in regions with normal bone marrow that are caused by human antimouse antibody (HAMA) formation. An infection or the entire extent of inflammation can be proven or excluded only at 24 hours postinjection. In contrast, antigranulocyte Fab'-fragment may have its advantage in an earlier localization of infectious lesions (1 hour) owing to its smaller molecular size and its lower affinity for its epitope. This may be promising in the detection of spinal infections and in infections in regions with the presence of normal bone marrow. Also advantageous is the negligible HAMA response rate. Problems may arise in abdominal infections because of an intestinal excretion of activity as early as 4 hours postinjection in some cases but more usually at 24 hours. © 1994 W. B. Saunders Company. All rights reserved.
引用
收藏
页码:142 / 153
页数:12
相关论文
共 64 条
[1]  
ABDEL-NABI H, 1989, Journal of Nuclear Medicine, V30, P748
[2]   IMMUNOSCINTIGRAPHIC LOCALIZATION OF INFLAMMATORY LESIONS - CONCEPT, RADIOLABELLING AND INVITRO TESTING OF A GRANULOCYTE SPECIFIC ANTIBODY [J].
ANDRES, RY ;
SCHUBIGER, PA ;
TIEFENAUER, L ;
SEYBOLD, K ;
LOCHER, JT ;
MACH, JP ;
BUCHEGGER, F .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 13 (11) :582-586
[3]  
BAIR HJ, 1991, NUKLEARMED, V30, P149
[4]   IN-111-LABELLED GRANULOCYTES IN INFLAMMATORY HEART-DISEASES [J].
BECKER, W ;
BORST, U ;
MAISCH, B ;
EPPING, J ;
BORNER, W ;
KOCHSIEK, K .
EUROPEAN HEART JOURNAL, 1987, 8 :307-310
[5]   KINETIC DATA OF INVIVO LABELED GRANULOCYTES IN HUMANS WITH A MURINE TC-99M-LABELED MONOCLONAL-ANTIBODY [J].
BECKER, W ;
BORST, U ;
FISCHBACH, W ;
PASURKA, B ;
SCHAFER, R ;
BORNER, W .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1989, 15 (07) :361-366
[6]  
BECKER W, 1986, J NUCL MED, V27, P1109
[7]   IN-111 OXINE-LABELED WHITE BLOOD-CELLS IN THE DIAGNOSIS AND FOLLOW-UP OF CROHNS-DISEASE [J].
BECKER, W ;
FISCHBACH, W ;
JENETT, M ;
REINERS, C ;
BORNER, W .
KLINISCHE WOCHENSCHRIFT, 1986, 64 (03) :141-148
[8]  
BECKER W, 1987, EUR J NUCL MED, V13, P225
[9]   INVIVO VIABILITY OF IN-111-LABELLED GRANULOCYTES DEMONSTRATED IN A SHAM-DIALYSIS MODEL [J].
BECKER, W ;
SCHAEFER, RM ;
BORNER, W .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (737) :463-467
[10]   SIGNIFICANCE OF LEUKOCYTE SCANNING IN INFECTED ENDOPROSTHESES [J].
BECKER, W ;
PASURKA, B ;
BORNER, W .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NUKLEARMEDIZIN, 1989, 150 (03) :284-289